The Long-Acting Ca2+-Channel Blocker Azelnidipine Prevents Left Ventricular Remodeling After Myocardial Infarction

The Long-Acting Ca2+-Channel Blocker Azelnidipine Prevents Left Ventricular Remodeling After Myocardial Infarction

Long-acting Ca2+-channel blockers have been reported to be effective in treating ischemic heart disease. However, their effects on cardiac remodeling after myocardial infarction (MI) are still unclear. We performed this study to examine the effect of azelnidipine on left ventricular (LV) remodeling,...

Full description

Bibliographic Details
Main Authors:	Daisuke Nishiya, Soichiro Enomoto, Takashi Omura, Ryo Matsumoto, Takanori Kusuyama, Yasukatsu Izumi, Hiroshi Iwao, Kazuhide Takeuchi, Minoru Yoshiyama
Format:	Article
Language:	English
Published:	Elsevier 2007-01-01
Series:	Journal of Pharmacological Sciences
Online Access:	http://www.sciencedirect.com/science/article/pii/S1347861319342938

Similar Items

Effects of Erythropoietin on Cardiac Remodeling After Myocardial Infarction
by: Nishiya Daisuke, et al.
Published: (2006-01-01)

Angiotensin Blockade Inhibits Osteopontin Expression in Non-infarcted Myocardium After Myocardial Infarction
by: Takanori Kusuyama, et al.
Published: (2005-01-01)

Effects of Treatment for Diabetes Mellitus on Circulating Vascular Progenitor Cells
by: Takanori Kusuyama, et al.
Published: (2006-01-01)

The Effects of HMG-CoA Reductase Inhibitor on Vascular Progenitor Cells
by: Kusuyama Takanori, et al.
Published: (2006-01-01)

Granulocyte-Colony Stimulating Factor Augments Neovascularization Induced by Bone Marrow Transplantation in Rat Hindlimb Ischemia
by: Yasuhiro Takagi, et al.
Published: (2005-01-01)

Tolvaptan Attenuates Left Ventricular Fibrosis After Acute Myocardial Infarction in Rats
by: Takanori Yamazaki, et al.
Published: (2013-01-01)

Percutaneous carbon dioxide mist treatment has protective effects in experimental myocardial infarction
by: Takehiro Yamaguchi, et al.
Published: (2015-04-01)

Clinical use of azelnidipine in the treatment of hypertension in Chinese patients
by: Chen BL, et al.
Published: (2015-02-01)

Azelnidipine protects myocardium in hyperglycemia-induced cardiac damage
by: Puranik Amrutesh S, et al.
Published: (2010-12-01)

Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study
by: Takami T, et al.
Published: (2011-06-01)

The impact of dose of the angiotensin-receptor blocker valsartan on the post-myocardial infarction ventricular remodeling: study protocol for a randomized controlled trial
by: Cho Young-Rak, et al.
Published: (2011-11-01)

Comparative Effects of Azelnidipine and Amlodipine on Myocardial Function and Mortality After Ischemia/Reperfusion in Dogs
by: Seiichiro Kano, et al.
Published: (2011-01-01)

A study of the use of β-blocker in acute stage of acute coronary syndromes in the prevention of left ventricular remodeling
by: Sow-Fei Lai, et al.
Published: (2004)

Nanoparticles for post-infarct ventricular remodeling
by: Dong, C., et al.
Published: (2018)

Left ventricular remodeling in patients with right ventricular myocardial infarction
by: M. T. Beyshenkulov,, et al.
Published: (2015-12-01)

Left ventricular remodeling in patients with right ventricular myocardial infarction
by: M. T. Beyshenkulov,, et al.
Published: (2015-12-01)

Therapeutic Potential of Vasopressin-Receptor Antagonists in Heart Failure
by: Yasukatsu Izumi, et al.
Published: (2014-01-01)

Cardioprotective Effect of SEA0400, a Selective Inhibitor of the Na+/Ca2+ Exchanger, on Myocardial Ischemia-Reperfusion Injury in Rats
by: Minoru Yoshiyama, et al.
Published: (2004-01-01)

Effects of Azelnidipine-Carboxymethylcellulose Gel on Healing of Full-Thickness Skin Wounds in Streptozotocin Induced Diabetic Rats
by: Karami MY, et al.
Published: (2019-12-01)

Azelnidipine inhibits cultured rat aortic smooth muscle cell death induced by cyclic mechanical stretch.
by: Jing Zhao, et al.
Published: (2014-01-01)

Comparison of Azelnidipine and Trichlormethiazide in Japanese Type 2 Diabetic Patients with Hypertension: The COAT Randomized Controlled Trial.
by: Masahiro Takihata, et al.
Published: (2015-01-01)

A New Baroreceptor Sensitivity-Restoring Ca-Channel Blocker Diminishes Age-Related Morning Blood Pressure Increase in Hypertensive Patients: Open-Label Monitoring of Azelnidipine Treatment for Hypertension in the Early Morning (At-HOME) Study
by: Mitsunori Sugiyama, et al.
Published: (2010-01-01)

Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis
by: Kain Vasundhara, et al.
Published: (2011-11-01)

Azelnidipine Down-Regulates Renal Angiotensin-Converting Enzyme and Mineralocorticoid Receptor mRNA in Diabetic Hypertensive Rats
by: Tetsuya Nakamura, et al.
Published: (2006-01-01)

Core-in-cup/liquisol dual tackling effect on azelnidipine buccoadhesive tablet micromeritics, in vitro release, and mucoadhesive strength
by: Rashad Amira A., et al.
Published: (2019-09-01)

Effects of losartan on ventricular remodeling in experimental infarction in rats
by: Zornoff Leonardo A. M., et al.
Published: (2000-01-01)

Factors Affecting Ventricular Remodeling Post Myocardial Infarction
by: Agarwal, Udit
Published: (2010)

Simulation of ventricular rate control during atrial fibrillation using ionic channel blockers
by: Shin Inada, PhD, et al.
Published: (2017-08-01)

Promoter Polymorphism of RGS2 Gene Is Associated with Change of Blood Pressure in Subjects with Antihypertensive Treatment: The Azelnidipine and Temocapril in Hypertensive Patients with Type 2 Diabetes Study
by: Ken Sugimoto, et al.
Published: (2010-01-01)

Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between Azelnidipine and amlodipine on glucose tolerance and endothelial function - a crossover trial (AGENT)
by: Kurata Takeshi, et al.
Published: (2011-09-01)

The effects of nifekalant hydrochloride on the spatial dispersion of repolarization after direct current defibrillation in patients with oral amiodarone and β-blocker therapy
by: Keiko Maeda, et al.
Published: (2014-06-01)

Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial
by: Takami T, et al.
Published: (2013-03-01)

Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial
by: Takami T, et al.
Published: (2013-04-01)

Repositioning Azelnidipine as a Dual Inhibitor Targeting CD47/SIRPα and TIGIT/PVR Pathways for Cancer Immuno-Therapy
by: Xiuman Zhou, et al.
Published: (2021-05-01)

Flecainide reduces ventricular arrhythmias via a mechanism that differs from that of β-blockers in catecholaminergic polymorphic ventricular tachycardia
by: Kenichi Dochi, et al.
Published: (2013-10-01)

Beneficial Effect of Candesartan on Rat Diastolic Heart Failure
by: Ryotaro Wake, et al.
Published: (2005-01-01)

Pretreatment with an angiotensin II receptor blocker abolished ameliorating actions of adipose-derived stem cell sheets on cardiac dysfunction and remodeling after myocardial infarction
by: Kenshiro Yamamoto, et al.
Published: (2018-12-01)

PREDICTORS OF ADVERSE LEFT VENTRICULAR REMODELING IN PATIENTS AFTER MYOCARDIAL INFARCTION
by: E S Zharikova, et al.
Published: (2017-12-01)

Are there gender differences in left ventricular remodeling after myocardial infarction in rats?
by: Ednei Luiz Antonio, et al.
Published: (2015-02-01)

Novel therapies for prevention of left ventricular remodeling following myocardial infarction
by: Liao, Songyan, et al.
Published: (2014)